Holen Sie sich die Stockscreener-App
1.52
7.04%
0.10
Handel nachbörslich:
1.52
Schlusskurs vom Vortag:
$1.42
Offen:
$1.455
24-Stunden-Volumen:
451.02K
Relative Volume:
1.65
Marktkapitalisierung:
$80.55M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-51.47M
KGV:
-1.52
EPS:
-1
Netto-Cashflow:
$-47.50M
1W Leistung:
+0.00%
1M Leistung:
+20.63%
6M Leistung:
+7.04%
1J Leistung:
+2.70%
1-Tages-Spanne:
$1.4298
$1.58
1-Wochen-Bereich:
$1.3801
$1.58
52-Wochen-Spanne:
$0.81
$1.82
Pmv Pharmaceuticals Inc Stock (PMVP) Company Profile
Firmenname
Pmv Pharmaceuticals Inc
Sektor
Branche
Telefon
(609) 642-6670
Adresse
400 ALEXANDER PARK DRIVE, PRINCETON
Vergleichen Sie PMVP mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PMVP
Pmv Pharmaceuticals Inc
|
1.52 | 75.25M | 0 | -51.47M | -47.50M | -1.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.92 | 99.42B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.55 | 58.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.52 | 56.35B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
646.60 | 39.02B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
307.51 | 34.25B | 3.81B | -644.79M | -669.77M | -6.24 |
Pmv Pharmaceuticals Inc Stock (PMVP) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-11-08 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2024-05-13 | Eingeleitet | Craig Hallum | Buy |
| 2024-04-12 | Eingeleitet | Jefferies | Buy |
| 2023-12-27 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2022-03-02 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2021-09-22 | Hochstufung | Goldman | Neutral → Buy |
| 2021-08-19 | Eingeleitet | Oppenheimer | Perform |
| 2021-08-02 | Eingeleitet | Guggenheim | Buy |
| 2021-07-29 | Eingeleitet | H.C. Wainwright | Buy |
| 2020-10-20 | Eingeleitet | BofA Securities | Buy |
| 2020-10-20 | Eingeleitet | Cowen | Outperform |
| 2020-10-20 | Eingeleitet | Evercore ISI | Outperform |
| 2020-10-20 | Eingeleitet | Goldman | Neutral |
Alle ansehen
Pmv Pharmaceuticals Inc Aktie (PMVP) Neueste Nachrichten
Can technical indicators confirm PMV Pharmaceuticals Inc.’s reversalForecast Cut & Fast Exit/Entry Strategy Plans - Newser
Multi asset correlation models including PMV Pharmaceuticals Inc.Bond Market & AI Forecasted Entry and Exit Points - Newser
Short Term Charts Align With Long Term Uptrend in PMV Pharmaceuticals Inc.July 2025 Trends & Proven Capital Preservation Tips - beatles.ru
What analysts say about PMV Pharmaceuticals Inc. stock outlookQuarterly Market Review & Fast Gain Stock Trading Tips - Newser
PMV Pharmaceuticals Inc. recovery potential after sell offJuly 2025 Momentum & Risk Managed Investment Entry Signals - Newser
How to integrate PMV Pharmaceuticals Inc. into portfolio analysis toolsAnalyst Upgrade & Weekly Watchlist of Top Performers - Newser
Technical signs of recovery in PMV Pharmaceuticals Inc.High Accuracy Trade Setup Identification - Newser
Heatmap analysis for PMV Pharmaceuticals Inc. and competitorsFree Smart Money Tracking Signal Generator - Newser
Risk vs reward if holding onto PMV Pharmaceuticals Inc.Free Early Entry Picks Before News Breakout - Newser
Why PMV Pharmaceuticals Inc. stock attracts strong analyst attentionWeekly Market Direction and Sector Summary - Newser
Is PMV Pharmaceuticals Inc. reversing from oversold territoryROI Focused Setup Screener With Exit Markers - Newser
PMV Pharmaceuticals Reports Q2 2025 Financial Results - TipRanks
What makes PMV Pharmaceuticals Inc. stock price move sharplySafe Momentum Strategy With Trend Analysis - Newser
Is PMV Pharmaceuticals Inc. forming a reversal patternFree AI Screening for Swing Trade Picks - Newser
How high can PMV Pharmaceuticals Inc. stock goSwing Trade Watchlist with Entry Zones - Newser
Is PMV Pharmaceuticals Inc. a candidate for recovery playTechnical Reversal Setup with Risk Limits - Newser
Can you recover from losses in PMV Pharmaceuticals Inc.Momentum-Based Prediction for Quick Returns - Newser
Earnings visualization tools for PMV Pharmaceuticals Inc.Free Capital Preserving Trade Plan Templates - Newser
Will PMV Pharmaceuticals Inc. rebound enough to break evenEntry Optimization Tool with Screener Logic - Newser
Should you hold or exit PMV Pharmaceuticals Inc. nowSummary of Consistent Growth Stock Picks - Newser
Top chart patterns to watch in PMV Pharmaceuticals Inc.Free Alpha Focused Technical Trade Signals - Newser
What MACD and RSI say about PMV Pharmaceuticals Inc.Free Alpha Focused Technical Trade Signals - Newser
Should you wait for a breakout in PMV Pharmaceuticals Inc.High Conviction Stock Long-Term Summary - Newser
Published on: 2025-08-08 18:31:10 - Newser
Analyzing recovery setups for PMV Pharmaceuticals Inc. investorsAsset Growth Pattern and Return Summary - Newser
PMV Pharmaceuticals (PMVP) Q2 Loss Jumps - AOL.com
PMV Pharmaceuticals Reports Second Quarter 2025 Financial Results and Corporate Highlights - GlobeNewswire
PMV Pharmaceuticals Inc reports results for the quarter ended June 30Earnings Summary - TradingView
PMV Pharmaceuticals Reports Q2 GAAP EPS of -$0.41, Misses by $0.02 - AInvest
PMV Pharmaceuticals Pours Cash Into R&D, Analysts Stay Bullish - Finimize
PMV Pharmaceuticals Reports Second Quarter 2025 Financial Results and Corporate Highlights | PMVP Stock News - GuruFocus
Evaluating PMV Pharmaceuticals' Path to Value Creation Amid Q2 2025 Losses and PYNNACLE Trial Progress - AInvest
PMV Pharmaceuticals, Inc. to Host Investor Webinar on Phase 2 PYNNACLE Clinical Trial Interim Analysis on September 10, 2025 - Quiver Quantitative
PMV Pharma to Reveal Phase 2 PYNNACLE Trial Results: 65 Cancer Patients, $148M Cash Through 2026 - Stock Titan
Pmv Pharmaceuticals Inc reports Q2 net loss of $21.2 million - MarketScreener
PMV Pharmaceuticals (PMVP) to Release Quarterly Earnings on Thursday - Defense World
Is a relief rally coming for PMV Pharmaceuticals Inc. holdersEarly Entry Planner for Swing Candidates - Newser
PMV Pharmaceuticals Inc. Stock Performance After Earnings: Historical InsightsFree Trade Setups With AI Powered Filters - Newser
Finanzdaten der Pmv Pharmaceuticals Inc-Aktie (PMVP)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):